Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125358851 | 12535885 | 1 | I | 20160627 | 20160707 | 20160707 | EXP | US-VIIV HEALTHCARE LIMITED-US2016092027 | VIIV | 0.00 | M | Y | 0.00000 | 20160707 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125358851 | 12535885 | 1 | SS | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | UNK, PRN | U | 6ZP3677 | 0 | CAPSULE | |||||||
| 125358851 | 12535885 | 2 | PS | TRIUMEQ | ABACAVIR SULFATEDOLUTEGRAVIR SODIUMLAMIVUDINE | 1 | Oral | UNK | U | 67P5429 | 205551 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125358851 | 12535885 | 1 | Product used for unknown indication |
| 125358851 | 12535885 | 2 | HIV infection |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125358851 | 12535885 | Abdominal pain upper |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125358851 | 12535885 | 1 | 2011 | 0 | ||
| 125358851 | 12535885 | 2 | 20160617 | 0 |